IL-23 secreted by myeloid cells drives castration-resistant prostate cancer

Arianna Calcinotto(Institute of Oncology Research), Clarissa Spataro(Institute of Oncology Research), Elena Zagato(Institute of Oncology Research), Diletta Di Mitri(Institute of Oncology Research), Veronica Gil(Royal Marsden NHS Foundation Trust), Mateus Crespo(Royal Marsden NHS Foundation Trust), Gaston De Bernardis(Institute of Oncology Research), Marco Losa(Institute of Oncology Research), Michela Mirenda(Institute of Oncology Research), Emiliano Pasquini(Institute of Oncology Research), Andrea Rinaldi(Institute of Oncology Research), Semini Sumanasuriya(Royal Marsden NHS Foundation Trust), Maryou Lambros(Royal Marsden NHS Foundation Trust), Antje Neeb(Institute of Cancer Research), Roberta Lucianò(IRCCS Ospedale San Raffaele), Carlo Andrea Bravi(IRCCS Ospedale San Raffaele), Daniel Nava Rodrigues(Royal Marsden NHS Foundation Trust), David Dolling(Royal Marsden NHS Foundation Trust), Tommaso Prayer‐Galetti(University of Padua), Ana Ferreira(Institute of Cancer Research), Alberto Briganti(IRCCS Ospedale San Raffaele), Antonio Esposito(San Raffaele University of Rome), Simon T. Barry(AstraZeneca (United Kingdom)), Wei Yuan(Institute of Cancer Research), Adam Sharp(Institute of Cancer Research), Johann S. de Bono(Institute of Cancer Research), Andrea Alimonti(Veneto Institute of Molecular Medicine)
Nature
June 26, 2018
Cited by 387

Abstract


Related Papers

No related papers found

Powered by citation graph analysis